PortfoliosLab logo
BBH vs. BIB
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between BBH and BIB is 0.64, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.


-0.50.00.51.0
Correlation: 0.6

Performance

BBH vs. BIB - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VanEck Vectors Biotech ETF (BBH) and ProShares Ultra Nasdaq Biotechnology (BIB). The values are adjusted to include any dividend payments, if applicable.

400.00%500.00%600.00%700.00%800.00%NovemberDecember2025FebruaryMarchApril
419.86%
506.15%
BBH
BIB

Key characteristics

Sharpe Ratio

BBH:

-0.23

BIB:

-0.24

Sortino Ratio

BBH:

-0.19

BIB:

-0.06

Omega Ratio

BBH:

0.98

BIB:

0.99

Calmar Ratio

BBH:

-0.13

BIB:

-0.15

Martin Ratio

BBH:

-0.53

BIB:

-0.60

Ulcer Index

BBH:

8.53%

BIB:

16.54%

Daily Std Dev

BBH:

19.63%

BIB:

41.50%

Max Drawdown

BBH:

-72.69%

BIB:

-67.24%

Current Drawdown

BBH:

-31.30%

BIB:

-59.23%

Returns By Period

In the year-to-date period, BBH achieves a -5.20% return, which is significantly higher than BIB's -11.72% return. Over the past 10 years, BBH has outperformed BIB with an annualized return of 1.92%, while BIB has yielded a comparatively lower -5.44% annualized return.


BBH

YTD

-5.20%

1M

-6.37%

6M

-12.26%

1Y

-3.09%

5Y*

0.32%

10Y*

1.92%

BIB

YTD

-11.72%

1M

-11.89%

6M

-27.13%

1Y

-7.29%

5Y*

-6.18%

10Y*

-5.44%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


BBH vs. BIB - Expense Ratio Comparison

BBH has a 0.35% expense ratio, which is lower than BIB's 0.95% expense ratio.


Expense ratio chart for BIB: current value is 0.95%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
BIB: 0.95%
Expense ratio chart for BBH: current value is 0.35%, compared with the broader market range of 0.00% to 2.12%.0.50%1.00%1.50%2.00%
BBH: 0.35%

Risk-Adjusted Performance

BBH vs. BIB — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

BBH
The Risk-Adjusted Performance Rank of BBH is 1010
Overall Rank
The Sharpe Ratio Rank of BBH is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of BBH is 1010
Sortino Ratio Rank
The Omega Ratio Rank of BBH is 1010
Omega Ratio Rank
The Calmar Ratio Rank of BBH is 1212
Calmar Ratio Rank
The Martin Ratio Rank of BBH is 1111
Martin Ratio Rank

BIB
The Risk-Adjusted Performance Rank of BIB is 1111
Overall Rank
The Sharpe Ratio Rank of BIB is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of BIB is 1313
Sortino Ratio Rank
The Omega Ratio Rank of BIB is 1313
Omega Ratio Rank
The Calmar Ratio Rank of BIB is 1111
Calmar Ratio Rank
The Martin Ratio Rank of BIB is 1010
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

BBH vs. BIB - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for VanEck Vectors Biotech ETF (BBH) and ProShares Ultra Nasdaq Biotechnology (BIB). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


The chart of Sharpe ratio for BBH, currently valued at -0.23, compared to the broader market-1.000.001.002.003.004.00
BBH: -0.23
BIB: -0.24
The chart of Sortino ratio for BBH, currently valued at -0.19, compared to the broader market-2.000.002.004.006.008.00
BBH: -0.19
BIB: -0.06
The chart of Omega ratio for BBH, currently valued at 0.98, compared to the broader market0.501.001.502.00
BBH: 0.98
BIB: 0.99
The chart of Calmar ratio for BBH, currently valued at -0.13, compared to the broader market0.002.004.006.008.0010.0012.00
BBH: -0.13
BIB: -0.15
The chart of Martin ratio for BBH, currently valued at -0.53, compared to the broader market0.0020.0040.0060.00
BBH: -0.53
BIB: -0.60

The current BBH Sharpe Ratio is -0.23, which is comparable to the BIB Sharpe Ratio of -0.24. The chart below compares the historical Sharpe Ratios of BBH and BIB, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50NovemberDecember2025FebruaryMarchApril
-0.23
-0.24
BBH
BIB

Dividends

BBH vs. BIB - Dividend Comparison

BBH's dividend yield for the trailing twelve months is around 0.84%, less than BIB's 2.12% yield.


TTM2024202320222021202020192018201720162015
BBH
VanEck Vectors Biotech ETF
0.84%0.80%0.43%0.47%0.21%0.36%0.34%0.50%0.55%0.30%0.27%
BIB
ProShares Ultra Nasdaq Biotechnology
2.12%1.69%0.07%0.03%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Drawdowns

BBH vs. BIB - Drawdown Comparison

The maximum BBH drawdown since its inception was -72.69%, which is greater than BIB's maximum drawdown of -67.24%. Use the drawdown chart below to compare losses from any high point for BBH and BIB. For additional features, visit the drawdowns tool.


-70.00%-60.00%-50.00%-40.00%-30.00%-20.00%NovemberDecember2025FebruaryMarchApril
-31.30%
-59.23%
BBH
BIB

Volatility

BBH vs. BIB - Volatility Comparison

The current volatility for VanEck Vectors Biotech ETF (BBH) is 11.42%, while ProShares Ultra Nasdaq Biotechnology (BIB) has a volatility of 24.42%. This indicates that BBH experiences smaller price fluctuations and is considered to be less risky than BIB based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


5.00%10.00%15.00%20.00%25.00%NovemberDecember2025FebruaryMarchApril
11.42%
24.42%
BBH
BIB